Literatur

[1] Miyakis S et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295–306

[2] Levine J S et al. The antiphospholipid syndrome N Eng J Med 2002; 346:752-63

[3] Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999; 353:1348–1353

[4] Cervera R et al. Antiphospholipid syndrome. Clinical and immunological manifestation an patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46:1019–1027

[5] Erkan D et al. Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms. Autoimmun Rev 2010 Dec; 10(2):74–79

[6] Pengo V et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7:1737–1740

[7] Rand J H et al. Dos and don`ts in diagnosing antiphospholipid syndrome. Hematol Am Soc Hematol Educ Progr 2012; 455–459

[8] Bertolaccini M L et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostic and trends. Autoimmunity Reviews 2013; 13:917–930

[9] Devreese K M J et al. Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC oft he ISTH. J Thromb Haemost 2014; 12:792–795

[10] Keeling D et al. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012; 157:47–58

[11] https://es.slideshare.net/junisbel/lupus-eritematoso-sistmico-y-sx-antifosfolipidico